MIT researchers have created a blueberry-sized ingestible temperature sensor that continuously measures core body temperature from inside the gastrointestinal tract, enabling earlier infection detection and safer monitoring for vulnerable patients.
MIT engineers have developed a miniature ingestible sensor capable of continuously measuring core body temperature from inside the gastrointestinal tract, marking a significant advance in medical electronics and remote patient monitoring. The technology could help clinicians detect infections earlier and monitor vulnerable patients more accurately than conventional temperature measurement methods.
The sensor is remarkably compact, measuring just 6 millimetres in diameter and 4 millimetres in height—roughly the size of a small blueberry. Its dimensions make it substantially smaller than existing ingestible temperature-monitoring capsules, which are typically as large as multivitamin pills and can be difficult for some patients to swallow. The reduced size also lowers the risk of gastrointestinal obstruction, a concern associated with larger capsule-based monitoring systems.
Unlike conventional thermometers that capture only periodic readings, the new device continuously transmits temperature data from within the body. Researchers say this capability could be particularly valuable for immunocompromised patients, including those undergoing chemotherapy or taking immunosuppressive medications, where early identification of infection can significantly improve treatment outcomes.
The breakthrough addresses a long-standing challenge in medical electronics: obtaining accurate core body temperature measurements without invasive procedures. External temperature readings can be influenced by environmental conditions and skin temperature, while traditional core-temperature methods often require uncomfortable probes or clinical supervision. Previous studies have shown that ingestible temperature sensors provide a reliable approximation of core body temperature while offering greater comfort and mobility for patients.
Miniaturization was achieved by redesigning the sensor’s electronics and power architecture. Existing ingestible monitoring devices require larger batteries and more complex circuitry, increasing overall capsule size. The MIT team’s approach reduces these constraints while maintaining continuous wireless monitoring capability.
The development builds on growing interest in ingestible electronics for healthcare applications. Researchers worldwide are exploring smart capsules capable of monitoring temperature, pH levels, metabolites and other physiological markers throughout the digestive tract. Such technologies could eventually support personalised medicine, chronic disease management and real-time health monitoring outside hospital settings.
The sensor was reported in Nature Electronics and represents another step toward unobtrusive medical devices that can deliver continuous physiological data while minimising patient discomfort.
